Related Experiment Video
Updated: Jun 6, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Dose impaired relaxation of left ventricle affect early outcomes in CABG patients?
Jamshid Bagheri1, Fereshteh Rezakhanloo
1Department of Cardiovascular Surgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Jbagheri@sina.tums.ac.ir
Insights
Diastolic dysfunction may impact cardiac surgery outcomes. This study suggests impaired relaxation is a significant factor in predicting complications after coronary artery bypass grafting, even with normal ejection fraction.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Systolic dysfunction is a known prognostic factor in cardiac surgery.
- The predictive role of diastolic dysfunction, particularly impaired relaxation, is less understood.
Purpose of the Study:
- To evaluate diastolic dysfunction as a predictive factor for outcomes in patients undergoing isolated coronary artery bypass grafting (CABG).
Main Methods:
- Retrospective analysis of 872 patients undergoing isolated CABG between January 2008 and February 2009.
- Patients with normal left ventricular ejection fraction (>50%) were divided into two groups: without diastolic dysfunction (n=361) and with diastolic dysfunction (n=27).
- Comparison of demographic data, risk factors, complication rates, and mortality between the two groups.
Main Results:
- The group with diastolic dysfunction showed a higher overall complication rate (11.1% vs. 2.8%, P=0.05).
- No significant statistical difference was found in individual complication types or mortality rates (7.4% vs. 2.2%, P=0.1) between the groups.
- Mean age and prevalence of risk factors like diabetes, hypertension, and dyslipidemia were similar between groups.
Conclusions:
- Diastolic dysfunction, characterized by impaired relaxation, can be a clinically significant factor in assessing surgical outcomes for patients undergoing coronary artery bypass grafting.
- Further research is warranted to fully elucidate the impact of diastolic dysfunction on cardiac surgery prognosis.
Abstract:
Although systolic dysfunction is revealed as a prognostic factor in cardiac surgery, the role of diastolic dysfunction as a predictive factor is less evaluated. In this retrospective study from 872 patients that underwent isolated coronary artery bypass graft (Jan 2008-Feb 2009), 388 patients had normal left ventricular ejection fraction (>50%). These are divided in two groups, Group 1: 361 patients without diastolic dysfunction (impaired relaxation) and Group 2: 27 patients with diastolic dysfunction (impaired relaxation). Mean age in group 1 was 57.72 year and in group 2 was 61.16 year (P = 0.07). Risk factors such as diabetes mellitus, hypertention and dyslipidemia were similar. Although overall complication rate was higher in group 2 (11.1% vs. 2.8% P value 0.05), but when each complication was studied individually no significant statistical difference was found. Also no significant statistical difference was found in mortality (2.2% in group 1 vs 7.4% in group 2 P = 0.1). In conclusion, from clinical standpoint diastolic dysfunction can be an important factor in assessing surgical outcome in patients whom underwent coronary artery bypass grafting.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Mitral Stenosis I: Introduction
Heart Failure Drugs: β-Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy